Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma

NCT00927901 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Indacaterol maleate 400 μg
DRUG: Indacaterol acetate 400 μg
DRUG: Indacaterol xinafoate 400 μg
DRUG: Placebo to indacaterol

Sponsor

Novartis Pharmaceuticals